Henry Schein stock, healthcare distribution

Henry Schein stock trades below its yearly high after Q2 figures

Published on 09/25/2026 at 10:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Henry Schein stock stood at USD 85.53 on September 24, 2026, below its USD 92.18 yearly high. Adjusted EPS reached USD 1.27 in Q2, up 15.5 percent.

Isometrische 3D-Illustration der Lieferkette von Medizinprodukten von Produktion zu Klinik
Henry Schein US42548G1040 Wertschöpfungskette vom Hersteller über Lager bis zur Zahnarztpraxis isometrisch dargestellt, Illustration mit AI erstellt.

Henry Schein stock stood at USD 85.53 on Nasdaq on September 24, 2026, up 0.56 percent from the prior session and 7.21 percent below its 52-week high of USD 92.18. The second-quarter figures and revised 2026 guidance provide the central earnings reference, as Yahoo Finance reported on September 24, 2026.

Q2 earnings expand the base

Henry Schein generated USD 3.46 billion in second-quarter 2026 revenue, an increase of 6.7 percent from the prior-year quarter. Adjusted diluted EPS reached USD 1.27, up 15.5 percent from USD 1.10, while GAAP diluted EPS was USD 0.82 compared with USD 0.70 a year earlier, according to Globe and Mail.

The quality of the growth matters more than the headline revenue figure. Internal local-currency sales growth was 4.6 percent, while acquisitions contributed 0.7 percentage points and foreign exchange contributed 1.4 percentage points, leaving the operating performance tied primarily to underlying demand.

Guidance moves higher for 2026

Management now expects 2026 adjusted EPS of USD 5.29-5.39, representing growth of 6-8 percent against 2025 adjusted EPS of USD 4.97. The sales growth forecast also moved to 4.5-5.5 percent from 3-5 percent, according to Zacks.

The revised outlook gives investors a measurable benchmark for the second half of the year. It also places the USD 5.32 consensus estimate cited by Zacks inside the company guidance range, making execution against the upper end more important than the existence of a raise alone.

Credit capacity adds a balance sheet angle

On September 24, Henry Schein amended its revolving credit agreement, increasing total commitments from USD 1 billion to USD 1.25 billion and extending the facility termination date to September 19, 2031, according to Simply Wall St. The larger facility improves financial flexibility, while the Q2 operating figures remain the more direct test of the updated earnings range.

Stock remains below its yearly high

Henry Schein stock was priced at USD 85.53 on Nasdaq on September 24, 2026, with a market capitalization of USD 9,743,321,010. The distance from the USD 92.18 52-week high leaves the stock below its yearly peak while the revised EPS range supplies the next quantified earnings benchmark.

Henry Schein stock at a glance

  • Company: Henry Schein, Inc.
  • Ticker: HSIC
  • Trading venue: Nasdaq
  • Price as of September 24, 2026: USD 85.53
  • Market capitalization: USD 9,743,321,010 as of September 24, 2026
  • 52-week range: USD 61.95-92.18 as of September 24, 2026
  • Sector / Industry: Healthcare / Medical distribution

Disclaimer...

en | boerse | 70182526 |